Introductory Speech for Hal Dietz*  by McKusick, Victor A.
660 The American Journal of Human Genetics Volume 81 October 2007 www.ajhg.org
2006 CURT STERN AWARD ADDRESS
Introductory Speech for Hal Dietz*
Victor A. McKusick
From the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore
Address for correspondence and reprints: Dr. Victor A. McKusick, Blalock Building 1007, Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, MD
21205. E-mail: mckusick@peas.welch.jhu.edu
* Previously presented at the annual meeting of The American Society of Human Genetics, in New Orleans, on October 13, 2006.
Am. J. Hum. Genet. 2007;81:660–661.  2007 by The American Society of Human Genetics. All rights reserved. 0002-9297/2007/8104-0008$15.00
DOI: 10.1086/521408
Victor A. McKusick and Hal Dietz
For two reasons, I take special pleasure in presenting the
Curt Stern Award to Hal Dietz. In the first place, Dr. Stern
was an important tutor in my self-education in genetics.
In the second place, Hal has solved many of the mysteries
of a genetic disorder I began studying in the early 1950s:
mysteries of etiology (the mutational basis), mysteries of
pathogenesis (the role of the transforming-growth-factor
b–signaling pathway), and, perhaps (we certainly hope so),
mysteries of effective pharmacotherapy. That disorder is,
of course, Marfan syndrome.
Curt Stern was born in Germany and got a Ph.D. in
Berlin at the tender age of 21. He worked at the Kaiser
Wilhelm Institute with Richard Goldschmidt, who sent
him to Columbia University to work for 2 years, 1924–
1926, with Thomas Hunt Morgan in the famous “fly
room.” In 1933, Stern moved to the United States to es-
cape Nazi anti-Semitism. He first taught and researched at
the University of Rochester. His research was in classic
aspects of genetics, using Drosophila as his experimental
organism. While at Rochester, Stern developed a pioneer
course in human genetics. That course was the basis of
his classic Principles of Human Genetics, first published in
1949. Its influence can be gauged by the facts that the
three English editions sold a total of more than 62,000
copies and that the book was translated into six other
languages. In 1947, Stern moved to U. of California–Berke-
ley and finished his career there. He was president of this
society in 1957 and received its Allan Award in 1974.
Stern’s legacy to education in human genetics may be
as important as his research contributions. Stern was im-
portant to the development of medical genetics at Johns
Hopkins and to my personal development in the field. I
recently found detailed notes I made in 1953 outlining
the entirety of the 1949 edition of Stern’s text book. In
the early days of the Division of Medical Genetics, based
in the Moore Clinic of the Johns Hopkins Hospital, Stern
spent the month of January 1959 at the Hospital as lec-
turer in residence, residing literally “under the Dome,”
and giving 12 lectures, one each Monday, Wednesday, and
Friday for those 4 weeks. Given in the Hospital’s main
auditorium, Hurd Hall, all 12 lectures were well attended.
As in his textbook, Stern illustrated these lectures on the
“principles of human genetics” with examples from classic
genetics, in which he was rooted. Personally, from Stern’s
visit, I derived most from his perspective on linkage gene
mapping and the fundamental importance of the gene map
to the understanding of the genetics of any species. He
pointed out that the arrangement of genes on our chro-
mosomes is part of our anatomy, the implication being
that it is information fundamental to the understanding
of genetic disease. Stern’s anatomic metaphor is one I have
used extensively.
More ancient history: I first published on the Marfan
syndrome in Circulation in March 1955, in an article en-
titled “The cardiovascular aspects of Marfan’s syndrome,
a heritable disorder of connective tissue.” (Parenthetically,
that was the first time I used the expression “heritable
disorders of connective tissue” in print and the last time
I used the possessive form of the eponym, Marfan’s.) After
Marfan syndrome, I looked around for other pleiotropic
disorders that might be heritable disorders of connective
tissue and settled on four others: Ehlers-Danlos syndrome,
osteogenesis imperfecta, pseudoxanthoma elasticum, and
www.ajhg.org The American Journal of Human Genetics Volume 81 October 2007 661
Hurler syndrome (the prototype of the mucopolysacchar-
idoses). I studied in great detail, as I had done for Marfan
syndrome, all patients and families in these other four
categories seen at the Johns Hopkins Hospital. These five
disorders, with the Marfan syndrome as queen, were the
subjects of separate chapters in my monograph Heritable
Disorders of Connective Tissue, first published just 50 years
ago, in 1956.
I dedicated the book to Archibald Garrod and to all who
believe, as he did, that clinical investigation of hereditary
disorders can shed light on normal developmental and
biochemical mechanisms. Garrod had made that point
explicitly in “The lessons of rare maladies,” published in
Lancet in 1928, which I cited in my preface. In that paper,
Garrod quoted William Harvey, who had made the same
observation in 1657:
Nature is nowhere accustomed more openly to display
her secret mysteries than in cases where she shows traces
of her workings apart from the beaten path; nor is there
any better way to advance the proper practice of med-
icine than to give our minds to the discovery of the
usual law of nature by careful investigation of cases of
rarer forms of disease. For it has been found, in almost
all things, that what they contain of useful or applicable
nature is hardly perceived unless we are deprived of
them, or they become deranged in some way.
Hal Dietz has powerfully validated that Harveian-Gar-
rodian principle by his studies of Marfan syndrome and
related disorders. Hal graduated from Syracuse Medical
School summa cum laude and valedictorian in 1984. He
came to Johns Hopkins for residency in pediatrics and in
critical-care medicine, capped off by a 4th year as chief
resident in pediatrics. In 1988, Hal embarked on a fellow-
ship in pediatric cardiology and in genetics. In the course
of that, he took to research like a duck to water. His first
two papers, both published in 1991, were, one, confirming
the mapping of the Marfan locus to chromosome 15 and,
the second, his well-known paper using the positional
candidate-gene approach to identify the first mutation in
fibrillin-1 in Marfan syndrome—not a bad start for a new
investigator. Hal’s devotion to Marfan syndrome, both in
the clinic and in the laboratory, has continued unabated
in the 15 years since 1991, with description and molecular
characterization of the Marfan-like disorder that bears his
name, Loeys-Dietz syndrome, and with his work on the
pathogenesis and rational treatment of Marfan syndrome.
On the way, Hal has also done groundbreaking work on
the significance of nonsense-mediated mRNA decay in ge-
netic diseases.
Three general points about Hal and his work:
1. Whereas Hal’s work has corroborated the Harvey-
Garrod principle, it illustrates that clinical investiga-
tion of hereditary disorders by “standard” methods
of clinical study, although a fundamental and indis-
pensable starting point, is not sufficient for learning
“the lessons of rare maladies.” Special methods and
technology are required. Hal’s work has turned on
its head the idea we had in 1956 that Marfan syn-
drome represents simply an innate weakness of a
structural element of connective tissue. His work has
shown that the pathogenesis of Marfan syndrome is
more complex but at the same time, paradoxically,
more amenable to pharmacotherapy.
2. Hal’s work has always been close to the clinic. You
can call it “patient-oriented research”; you can call
it “translational research.” It is both. You could say
Hal is a scientist who takes care of patients or is a
clinician who does research. I would say that he is
an academic triathlete; he engages in the strenuous
academic triathlon of research, teaching, and patient
care—an integrated equitripartite career. He takes both
competence and empathy to the clinic, from which
he derives inspiration and intellectual challenge. He
teaches in both the clinic and the laboratory.
3. There is a special quality about the Dietz laboratory.
It has an excitement and enthusiasm that makes it
a magnet for the brightest and best who want to work
with Hal. He is a supportive mentor. He is a generous
colleague and collaborator.
Hal, it is with personal pleasure that I represent the
American Society of Human Genetics in presenting you
with this award named in honor of a pioneer in human
genetics education, Curt Stern.
